Home
OverviewAbout10 LeapsCollaborationImpact
OverviewLeaps TalksChapter FilmsLeaps.orgPartners
AgricultureHealth
OverviewAnnual ReviewBreakthrough StudyPress ReleasesIn the NewsReportsLeaps LeadershipPress KitMedia Contact
Team
  • Approach
    • Overview
    • About
    • 10 Leaps
    • Collaboration
    • Impact
  • Engagement
    • Overview
    • Leaps Talks
    • Chapter Films
    • Leaps.org
    • Partners
    • Agriculture
    • Health
  • News
    • Overview
    • Annual Review
    • Breakthrough Study
    • Press Releases
    • In the News
    • Reports
    • Leaps Leadership
    • Press Kit
    • Media Contact
  • Team
ContactImprintPrivacy StatementConditions of Use
sign up for our newsletter
see more companies

Mozart Therapeutics


mozart therapeutics health logo

Vision

hange the treatment paradigm for patients with autoimmune and inflammatory diseases.

Approach

Mozart is focused on developing disease-modifying therapies for autoimmune and inflammatory diseases. They aim to reset and restore the balance of the immune system by leveraging a novel pathway to develop first-in-class CD8 Treg modulators to delay onset, reduce severity and potentially reverse the course of disease that allow patients to lead normal lives.

Mozart Therapeutics is addressing

  • Leap 06 / Reverse autoimmune diseases and chronic inflammation

CEO:

Katie Fanning

Founders:

Mark M. Davis, PhD

K. Christopher Garcia, PhD

Calvin Kuo, MD, PhD

First investment:

April 2021

www.mozart-tx.com